ISOVUE 200 INJECTION
ISOVUE 200 INJECTION
Approved
DIN Number
02229013
Drug Class
Human
Market Date
Jan 8, 1998
Company
HC
E-Z-Em Canada Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02229013
AIG Number0116899004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AB04 IOPAMIDOL
Product Specifications
Dosage FormSolution
Route of AdministrationSubarachnoidal
,
Intravascular
AHFS Classification36:68.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IOPAMIDOLActive
Strength: 41 %
Monograph: IOPAMIDOL